IIL to invest Rs.700 Cr. for a new Animal Vaccine facility

Indian Immunologicals (IIL) announced I Limited that the company will invest about INR 700 Crores to set up a new animal vaccine manufacturing facility in Genome Valley, Hyderabad the "Vaccine Hub of the World", to meet the vaccine security of the nation against economically important diseases such as Foot and Mouth disease (FMD) and other emerging diseases.

The facility -will create total employment for around 750 people. IIL, a subsidiary National Dairy Development Board (NDDB) is already one of the largest manufacturers of FMD vaccine in the world and is the leading supplier of FMD vaccine to the Government of India's National Animal Disease Control Programme (NADCP). III is investing in a new greenfield project for the establishment of a Veterinary Vaccine Facility for manufacturing of Foot and Mouth Disease (FMD) vaccine and other animal vaccines. The facility is intended to be a stateof-art fully integrated biosafety level 3 (BSL-3) for Drug substance (DS) production and respective fillfinish. IIL's intended new facility, in Genome Valley Phase 3, will add another 300 million doses/annum of FMD vaccine to its capacity.